Skip to main
SIBN

SI-BONE Inc (SIBN) Stock Forecast & Price Target

SI-BONE Inc (SIBN) Analyst Ratings

Based on 6 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

SI-BONE is a strong player in the medical device industry, offering a proprietary minimally invasive surgical implant system that is gaining traction in the market. Their recent strategic partnership with Smith Nephew is expected to drive revenue growth in 2026 and beyond. The company has a diverse product portfolio with multiple upcoming launches, positioning them for sustained growth. Risks include potential reimbursement challenges and competition.

Bears say

SI-BONE is expected to have a strong fourth quarter due to their solid beat on guided numbers in the third quarter, as well as potential upside to the Street's 2026 revenue from product launches and reimbursement tailwinds. However, there are potential risks in the market, such as slower adoption in the SI joint fusion market, which may impact revenue growth and lead to higher cash burn. Additionally, the current EV/sales multiple of 4x our 2027E estimate may be overvalued, suggesting a decline in stock price in the long term.

SI-BONE Inc (SIBN) has been analyzed by 6 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About SI-BONE Inc (SIBN) Forecast

Analysts have given SI-BONE Inc (SIBN) a Strong Buy based on their latest research and market trends.

According to 6 analysts, SI-BONE Inc (SIBN) has a Strong Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

SI-BONE Inc (SIBN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.